Activation-driven T cell death appears to represent the mechanism of clonal deletion in vivo, the principle mechanism by which T cell tolerance is achieved. Characterization of the process of activation-driven cell death in vitro in non-transformed, mature T cells and in transformed T cell hybridomas has demonstrated that the dying cell plays an active role in its own death. Activation-driven cell death occurs in a cell-autonomous manner, without effect on unstimulated bystander cells. This process is dependent on macromolecular synthesis, presumably reflecting the specific expression of genes involved in the cell suicide process. Susceptibility to activation-driven cell death is developmentally regulated. Our analyses of critical events in this and other cases of physiological cell death have led us to suggest that cell suicide represents the induction of an abortive mitosis - like process. The studies proposed here will explore the process of activation-driven T cell death on the molecular level. We will define the requirements for the induction of activation-driven cell death in immature T cells and we will characterize the developmental controls exerted on T cell susceptibility to cell death which influence positive and negative clonal selection. We will examine the activation-driven cell death process mechanistically by exploring the involvement of mitosis-like kinase activities in the phosphorylation-dependent events critical to cell death, especially nuclear envelope dissolution and cytoskeletal reorganization. We will test whether these activities represent authentic cell division control gene products on both the biochemical and genetic levels. An understanding of the mechanism and the physiological regulation of the process of activation-driven cell death in immunity will provide insight into the control of lymphocyte ontogeny and selection against autoimmune reactivity, as well as potential mechanisms of in vivo tumor control.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM038800-05
Application #
2179544
Study Section
Experimental Immunology Study Section (EI)
Project Start
1988-07-01
Project End
1995-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Fazal, Fabeha; Gu, Lianzhi; Ihnatovych, Ivanna et al. (2005) Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol 25:6259-66
Bondar, Tanya; Mirkin, Ekaterina V; Ucker, David S et al. (2003) Schizosaccharomyces pombe Ddb1 is functionally linked to the replication checkpoint pathway. J Biol Chem 278:37006-14
Quiambao, A B; Tan, E; Chang, S et al. (2001) Transgenic Bcl-2 expressed in photoreceptor cells confers both death-sparing and death-inducing effects. Exp Eye Res 73:711-21
Zou, X; Tsutsui, T; Ray, D et al. (2001) The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol Cell Biol 21:4818-28
Yu, R; Mandlekar, S; Harvey, K J et al. (1998) Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 58:402-8
Ucker, D S; Wilson, J D; Hebshi, L D (1994) Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms. Mol Cell Biol 14:427-36
Ucker, D S; Obermiller, P S; Eckhart, W et al. (1992) Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 12:3060-9
Ucker, D S; Ashwell, J D; Nickas, G (1989) Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 143:3461-9